21st Annual HIV CME Symposium: Tough Decisions Made Easier!

This one-day symposium is designed to provide participants with relevant, reliable, up-to-date information on the clinical management of HIV-related issues including: management of people with HIV with new or simplified treatment options, management of HIV related complications and the use of antivirals for the prevention of HIV in those at-risk.

Registration Fee

$65 In-Person Attendance

UC Recharge Payment Information
Registration payment can be submitted via the Interdepartmental or Intercampus recharge system.
For more details, please refer to document here: Recharge Information

Refunds
Due to the low enrollment fee, no refunds will be offered. A full refund will be provided if this course is cancelled, or postponed. David Geffen School of Medicine at UCLA reserves the right to cancel or postpone this course if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.

Course Recording
The course will not be recorded.

Questions
If you have questions about enrollment or Continuing Education related inquiries, please email ccpd@mednet.ucla.edu or call (310) 794-2620.

For questions about this program, please contact the Program Coordinator at (310) 825-6413 or email at caresymposium@mednet.ucla.edu.

Target Audience

Specialties - Family Medicine, Health Care Administration, Leadership, and Management, Infectious Disease, Internal Medicine, Pathology, Preventive Medicine, Public Health and General Preventive Medicine

Professions - Advanced Practice Nurse, Fellow/Resident, Nurse, Pharmacist, Physician, Scientist/ Researcher

Objectives

At the conclusion of this activity, learners will be able to:
 

1. Identify best practice for vaccinations of persons with HIV, including new insights on the use of modern Hepatitis B vaccination strategies
2. Recognize the opportunities and challenges with solid organ transplantation, bone marrow transplant, and CAR-T therapies in persons with HIV
3. Identify the challenges facing United States public health and where to find reliable sources of public health information
4. Identify novel HIV treatment agents in the development pipeline, with a focus on long-acting and extended-release agents and regimens
5. Describe recent advances in HIV Prevention, including use of Lenacapavir for PrEP and updates to post-exposure prophylaxis guidelines
6. Describe the data, guidelines, and limitations of the use of DoxyPEP for STI prevention

Accreditation

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA PRA Category 1 Credits™. as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.